Actively Recruiting

Phase 2
Phase 3
Age: 18Years - 40Years
FEMALE
NCT02741102

Uterine Transplant in Absolute Uterine Infertility (AUIF)

Led by Brigham and Women's Hospital · Updated on 2026-04-28

10

Participants Needed

1

Research Sites

87 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will examine the feasibility of initiating a uterine transplant program for Absolute Uterine Factor Infertility (AUFI) at Brigham and Women's Hospital. The investigators plan to screen 30 patients with a goal of enrolling 10 patients. (5 donors and 5 recipients) After careful screening, appropriate candidates will undergo IVF, Uterine Transplantation, Embryo Transfer, Pregnancy and Delivery. Once the uterus is explanted, five years of follow-up is planned.

CONDITIONS

Official Title

Uterine Transplant in Absolute Uterine Infertility (AUIF)

Who Can Participate

Age: 18Years - 40Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 40 years for recipients
  • Clinical diagnosis of Absolute Uterine Factor Infertility (AUFI)
  • Ability to produce at least 6 normal embryos by IVF
  • Body Mass Index (BMI) less than 30
  • Normal kidney function
  • Ability to undergo transplant and follow treatment plan
  • Stable partner and social support
  • Partner willing to have psychological evaluation and recommended immunizations
  • Stable home environment to support a child
  • Donor age 40 to 60 years
  • Donor has completed childbearing with previous full-term pregnancies
  • Donor able to take estrogen-containing birth control pills
  • Donor with BMI of 30 or less
  • Donor has good social support
Not Eligible

You will not qualify if you...

  • Active smoking, alcohol use, or illicit drug use
  • Inability to comply with treatment such as medication, biopsies, or appointments
  • Medical conditions making pregnancy or immunosuppressive treatment too risky
  • Active infections including HIV, Tuberculosis, Hepatitis B or C
  • History of extensive abdominal or pelvic surgery
  • History of abnormal Pap smear or genital warts
  • History of pelvic inflammatory disease
  • Donor psychiatric illness
  • Donor cervical or uterine polyps or tumors
  • Donor history of more than one Caesarian section
  • Donor internal scarring from surgery
  • Donor hypertension, coronary artery disease, COPD, or diabetes
  • Donor active or incompletely treated cancer
  • Donor history of blood clotting or bleeding disorders
  • Donor evidence of coercion or exchange for organ donation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

Loading map...

Research Team

S

Stefan G Tullius, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here